Search

Sean E. Aeder

Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1939
Issued Applications
907
Pending Applications
201
Abandoned Applications
855

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8707546 [patent_doc_number] => 20130064835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'RAGE REGULATES ROCK ACTIVITY IN CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 13/500885 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28012 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500885 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/500885
RAGE REGULATES ROCK ACTIVITY IN CARDIOVASCULAR DISEASE Oct 7, 2010 Abandoned
Array ( [id] => 6188731 [patent_doc_number] => 20110171641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy' [patent_app_type] => utility [patent_app_number] => 12/900388 [patent_app_country] => US [patent_app_date] => 2010-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28396 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171641.pdf [firstpage_image] =>[orig_patent_app_number] => 12900388 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/900388
Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy Oct 6, 2010 Abandoned
Array ( [id] => 8660065 [patent_doc_number] => 20130040894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'INHIBITION OR ACTIVATION OF SERINE/THREONINE ULK3 KINASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/500902 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10145 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500902 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/500902
INHIBITION OR ACTIVATION OF SERINE/THREONINE ULK3 KINASE ACTIVITY Oct 5, 2010 Abandoned
Array ( [id] => 8289791 [patent_doc_number] => 20120178111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS' [patent_app_type] => utility [patent_app_number] => 13/497629 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 46040 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497629 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/497629
METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS Sep 22, 2010 Abandoned
Array ( [id] => 5976005 [patent_doc_number] => 20110070268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-24 [patent_title] => 'Method' [patent_app_type] => utility [patent_app_number] => 12/884407 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 44242 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20110070268.pdf [firstpage_image] =>[orig_patent_app_number] => 12884407 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/884407
Method Sep 16, 2010 Abandoned
Array ( [id] => 6055071 [patent_doc_number] => 20110111431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'METHOD FOR IDENTIFYING PRE-NEOPLASTIC AND/OR NEOPLASTIC STATES IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/878865 [patent_app_country] => US [patent_app_date] => 2010-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7247 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111431.pdf [firstpage_image] =>[orig_patent_app_number] => 12878865 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/878865
METHOD FOR IDENTIFYING PRE-NEOPLASTIC AND/OR NEOPLASTIC STATES IN MAMMALS Sep 8, 2010 Abandoned
Array ( [id] => 5992549 [patent_doc_number] => 20110014202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'Methods for Diagnosing and Treating Neuroendocrine Cancer' [patent_app_type] => utility [patent_app_number] => 12/876312 [patent_app_country] => US [patent_app_date] => 2010-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13284 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014202.pdf [firstpage_image] =>[orig_patent_app_number] => 12876312 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/876312
Methods for diagnosing and treating neuroendocrine cancer Sep 6, 2010 Issued
Array ( [id] => 8227805 [patent_doc_number] => 20120142012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'BIOMARKER FOR COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/390532 [patent_app_country] => US [patent_app_date] => 2010-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9549 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390532 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/390532
Biomarker for colorectal cancer Sep 5, 2010 Issued
Array ( [id] => 8351849 [patent_doc_number] => 08247183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Compositions and methods for diagnosis and treatment of tumors' [patent_app_type] => utility [patent_app_number] => 12/871669 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 35088 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871669 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/871669
Compositions and methods for diagnosis and treatment of tumors Aug 29, 2010 Issued
Array ( [id] => 7779811 [patent_doc_number] => 20120041686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'DIAGNOSTIC FOR LUNG DISORDERS USING CLASS PREDICTION' [patent_app_type] => utility [patent_app_number] => 12/869525 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 32192 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041686.pdf [firstpage_image] =>[orig_patent_app_number] => 12869525 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/869525
DIAGNOSTIC FOR LUNG DISORDERS USING CLASS PREDICTION Aug 25, 2010 Abandoned
Array ( [id] => 6201961 [patent_doc_number] => 20110064747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)' [patent_app_type] => utility [patent_app_number] => 12/868678 [patent_app_country] => US [patent_app_date] => 2010-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 63735 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064747.pdf [firstpage_image] =>[orig_patent_app_number] => 12868678 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/868678
METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10) Aug 24, 2010 Abandoned
Array ( [id] => 5928903 [patent_doc_number] => 20110038862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHOD AND KIT FOR THE DETECTION OF GENES ASSOCIATED WITH PIK3CA MUTATION AND INVOLVED IN PI3K/AKT PATHWAY ACTIVATION IN THE ER-POSTITIVE AND HER2-POSITIVE SUBTYPES WITH CLINICAL IMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/860638 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14100 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038862.pdf [firstpage_image] =>[orig_patent_app_number] => 12860638 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/860638
Method and kit for the detection of genes associated with PIK3CA mutation and involved in PI3K/AKT pathway activation in the ER-postitive and HER2-positive subtypes with clinical implications Aug 19, 2010 Issued
Array ( [id] => 5935937 [patent_doc_number] => 20110212085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'LUNG CANCER DISEASE TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/859440 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44786 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212085.pdf [firstpage_image] =>[orig_patent_app_number] => 12859440 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/859440
LUNG CANCER DISEASE TARGETS AND USES THEREOF Aug 18, 2010 Abandoned
Array ( [id] => 9009160 [patent_doc_number] => 08524456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers' [patent_app_type] => utility [patent_app_number] => 12/859526 [patent_app_country] => US [patent_app_date] => 2010-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 28082 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859526 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/859526
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Aug 18, 2010 Issued
Array ( [id] => 8927913 [patent_doc_number] => 20130183673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'NEW MARKERS FOR THE EPITHELIAL AND PROLIFERATIVE OR MESENCHYMAL INVASIVE PHENOTYPE OF HUMAN NEOPLASIAS' [patent_app_type] => utility [patent_app_number] => 13/816339 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15530 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816339 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/816339
NEW MARKERS FOR THE EPITHELIAL AND PROLIFERATIVE OR MESENCHYMAL INVASIVE PHENOTYPE OF HUMAN NEOPLASIAS Aug 10, 2010 Abandoned
Array ( [id] => 6264901 [patent_doc_number] => 20100297658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'DETECTING METHYLATED MAMMALIAN NUCLEIC ACID IN STOOL' [patent_app_type] => utility [patent_app_number] => 12/851872 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4819 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297658.pdf [firstpage_image] =>[orig_patent_app_number] => 12851872 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/851872
DETECTING METHYLATED MAMMALIAN NUCLEIC ACID IN STOOL Aug 5, 2010 Abandoned
Array ( [id] => 6202350 [patent_doc_number] => 20110065136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'Methods and Devices for Detecting Glomerulonephritis and Associated Disorders' [patent_app_type] => utility [patent_app_number] => 12/852152 [patent_app_country] => US [patent_app_date] => 2010-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 17287 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065136.pdf [firstpage_image] =>[orig_patent_app_number] => 12852152 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/852152
Methods and Devices for Detecting Glomerulonephritis and Associated Disorders Aug 5, 2010 Abandoned
Array ( [id] => 5943565 [patent_doc_number] => 20110104185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'ANTIBODY FRAGMENT-POLYMER CONJUGATES AND USES OF SAME' [patent_app_type] => utility [patent_app_number] => 12/850490 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 144 [patent_figures_cnt] => 144 [patent_no_of_words] => 111610 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104185.pdf [firstpage_image] =>[orig_patent_app_number] => 12850490 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/850490
Antibody fragment-polymer conjugates and uses of same Aug 3, 2010 Issued
Array ( [id] => 6165739 [patent_doc_number] => 20110195478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/849988 [patent_app_country] => US [patent_app_date] => 2010-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5372 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195478.pdf [firstpage_image] =>[orig_patent_app_number] => 12849988 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/849988
BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME Aug 3, 2010 Abandoned
Array ( [id] => 8429704 [patent_doc_number] => 20120251579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-04 [patent_title] => 'COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/386590 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10507 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386590 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/386590
COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE Jul 29, 2010 Abandoned
Menu